Sucralose Non-Carcinogenicity: A Review of the Scientific and Regulatory Rationale. - Wikidata - wikimedia - TriplyDB

Sucralose Non-Carcinogenicity: A Review of the Scientific and Regulatory Rationale.

Sucralose Non-Carcinogenicity: A Review of the Scientific and Regulatory Rationale.

http://www.wikidata.org/entity/Q30831612

about

Health outcomes of non-nutritive sweeteners: analysis of the research landscape.Statement on the validity of the conclusions of a mouse carcinogenicity study on sucralose (E 955) performed by the Ramazzini Institute Characterization of the Types of Sweeteners Consumed in Honduras.

P2860

Q41468244-32FC3A23-26A9-4DEB-8AC1-9608634D4E12 Q47159441-1E840134-C66E-4D69-B393-352EA58D2B30 Q55000432-208A1041-E50D-4F58-BD19-A970AFBB4347

P2860

Sucralose Non-Carcinogenicity: A Review of the Scientific and Regulatory Rationale.

http://www.wikidata.org/entity/Q30831612

description

2016 nî lūn-bûn

@nan

2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

Sucralose Non-Carcinogenicity: A Review of the Scientific and Regulatory Rationale.

@ast

Sucralose Non-Carcinogenicity: A Review of the Scientific and Regulatory Rationale.

@en

type

label

Sucralose Non-Carcinogenicity: A Review of the Scientific and Regulatory Rationale.

@ast

Sucralose Non-Carcinogenicity: A Review of the Scientific and Regulatory Rationale.

@en

prefLabel

Sucralose Non-Carcinogenicity: A Review of the Scientific and Regulatory Rationale.

@ast

Sucralose Non-Carcinogenicity: A Review of the Scientific and Regulatory Rationale.

@en

P1433

Q30831612-7CD92310-14E5-4E6C-9A9A-0FE42AED9B9E

P1476

Q30831612-5DAA0E72-8E34-4000-89C6-44698687A1BE

P2093

Q30831612-1632EC0A-F87B-4F77-A84A-343538444DA5

Q30831612-6ADBCC1E-FF96-4C87-9B6D-64EA624D7521

Q30831612-6B3B7595-5832-48CC-86F3-058EC0DB12A8

Q30831612-84FCF77A-0700-4BAD-904A-60EFC14B5F13

Q30831612-8EE75305-29F4-49A8-B796-C8E2AF3CD124

Q30831612-EBF3F2D8-5488-4F89-BCB1-B7C86B127D1A

P275

Q30831612-6004E9CA-FE1D-40C1-A297-84558FD0247C

P2860

Q30831612-0356E11B-FB67-43F7-917A-A831FAC13448

Q30831612-04B582F6-1DFF-4542-82EC-44FD9BE10B6F

Q30831612-04BD6C3E-EEF1-43B7-A666-87722B622761

Q30831612-07D3D6E6-AD85-4458-A0C5-6B87DF8D1906

Q30831612-0AC9943B-A640-4973-9342-AED9DB16D546

Q30831612-174EF8D8-41B1-41C9-B522-231D2E15A932

Q30831612-1790C3AA-81C1-4258-AB53-03E9C80D8F54

Q30831612-272DFFD0-F472-48BA-8374-C2A1E890F803

Q30831612-285C30CC-4208-487F-8AF8-52CC8BCE0A7C

Q30831612-2C0721D6-3E80-41FD-BBC2-683FFC12EDBB

P304

Q30831612-E291E8A1-A94B-4B6F-BB4E-DA816B26328D

P31

Q30831612-96CCFF2F-69CB-42C7-9F72-45807F62C61A

Q30831612-9A164745-3802-4439-B0B7-26A74B07A1FA

P356

Q30831612-797F1E24-E4A2-441E-8BAA-71AE2C6716C0

P433

Q30831612-DD199F61-3EEA-40E5-8AD8-AFA4C36C6D8E

P478

Q30831612-DA4579B4-F599-461C-AE66-F69CCDEEE308

P577

Q30831612-4EF93DDF-BA05-4C77-8492-818A312EF52D

P698

Q30831612-47EB2726-E59E-4847-960B-971BD81B4C0F

P921

Q30831612-61614DAF-BD8B-49A2-B39A-23519B6F1B1A

Q30831612-96015196-AC24-4BA0-86F5-7C576F6FA4A6

Q30831612-D8C98F06-382C-439F-9FCD-E2BE3F1218A8

P932

Q30831612-8A18CDC8-731D-4B4B-AA09-810E0946176F

P356

01635581.2016.1224366

P1433

Nutrition and Cancer

P1476

Sucralose Non-Carcinogenicity: A Review of the Scientific and Regulatory Rationale.

@en

P2093

Colin Berry

http://www.w3.org/2001/XMLSchema#string

David Brusick

http://www.w3.org/2001/XMLSchema#string

Gary M Williams

http://www.w3.org/2001/XMLSchema#string

Jerry F Hardisty

http://www.w3.org/2001/XMLSchema#string

Samuel M Cohen

http://www.w3.org/2001/XMLSchema#string

V Lee Grotz

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

P2860

First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed to Sprague-Dawley rats.

DNA damage response genes and the development of cancer metastasis

Sucralose--an overview of the toxicity data.

Selection of appropriate tumour data sets for Benchmark Dose Modelling (BMD) and derivation of a Margin of Exposure (MoE) for substances that are genotoxic and carcinogenic: considerations of biological relevance of tumour type, data quality and unc

Scientific and Regulatory Policy Committee (SRPC) Review: Interpretation and Use of Cell Proliferation Data in Cancer Risk Assessment.

The refinement of uncertainty/safety factors in risk assessment by the incorporation of data on toxicokinetic variability in humans.

The metabolic fate of sucralose in rats.

Best practices for use of historical control data of proliferative rodent lesions.

Background to the ADI/TDI/PTWI.

Acute and subchronic toxicity of sucralose.

P304

1247-1261

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/01635581.2016.1224366

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27652616

http://www.w3.org/2001/XMLSchema#string

P921

Angliavandeniai

physiological phenomena

biomedical investigative technique

P932

5152540

http://www.w3.org/2001/XMLSchema#string